In melanoma, lung carcinoma, and colon tumors, suppressed tumor growth in CD39-deficient mice has been associated with decreased angiogenesis; CD39 co-expression with CD73 in endothelial cells will ultimately generate adenosine, which promotes angiogenesis (34). The gene discussed is ENTPD1; the disease is melanoma.